These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T; Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445 [TBL] [Abstract][Full Text] [Related]
24. [Epidemiological features of antibiotic resistance in Streptococcus pneumoniae strains isolated from patients with pneumococcal pneumonias]. Martynova AV Probl Tuberk Bolezn Legk; 2007; (12):47-9. PubMed ID: 18326216 [TBL] [Abstract][Full Text] [Related]
25. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones. Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924 [TBL] [Abstract][Full Text] [Related]
26. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia. Fogarty C; Torres A; Choudhri S; Haverstock D; Herrington J; Ambler J Int J Clin Pract; 2005 Nov; 59(11):1253-9. PubMed ID: 16236076 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R; J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376 [TBL] [Abstract][Full Text] [Related]
29. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Gosbell IB; Fernandes LA; Fernandes CJ Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725 [TBL] [Abstract][Full Text] [Related]
30. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Lynch III JP; Martinez FJ Clin Infect Dis; 2002 Mar; 34 Suppl 1():S27-46. PubMed ID: 11810608 [TBL] [Abstract][Full Text] [Related]
31. Drug treatment of pneumococcal pneumonia in the elderly. Neralla S; Meyer KC Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950 [TBL] [Abstract][Full Text] [Related]
32. [Streptococcus pneumoniae and beta-lactam antibiotic agents]. Ranin L; Vucković-Opavski N; Berger-Jekić O Srp Arh Celok Lek; 1996; 124(1-2):18-23. PubMed ID: 9102809 [TBL] [Abstract][Full Text] [Related]
33. [Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children and multidrug resistance]. Bayer M; Aslan G; Emekdaş G; Kuyucu N; Kanik A Mikrobiyol Bul; 2008 Apr; 42(2):223-30. PubMed ID: 18697420 [TBL] [Abstract][Full Text] [Related]
34. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Dagan R; Givon-Lavi N; Zamir O; Fraser D Pediatr Infect Dis J; 2003 Jun; 22(6):532-40. PubMed ID: 12799510 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia. Bhavnani SM; Forrest A; Hammel JP; Drusano GL; Rubino CM; Ambrose PG Diagn Microbiol Infect Dis; 2008 Sep; 62(1):99-101. PubMed ID: 18583085 [TBL] [Abstract][Full Text] [Related]
36. Cefuroxime for empiric treatment of community-acquired pneumococcal pneumonia: is there a generation gap? Wiener-Well Y; Raveh D; Schlesinger Y; Yinnon AM; Rudensky B Chemotherapy; 2009; 55(2):97-104. PubMed ID: 19145079 [TBL] [Abstract][Full Text] [Related]
37. [Alexander Project--5 years in Poland]. Hryniewicz W Pol Merkur Lekarski; 2003 Jan; 14(79):5-8. PubMed ID: 12712818 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan. Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022 [TBL] [Abstract][Full Text] [Related]
39. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P; Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184 [TBL] [Abstract][Full Text] [Related]
40. Controversies in the treatment of pneumococcal community-acquired pneumonia. Feldman C; Anderson R Future Microbiol; 2006 Oct; 1(3):271-81. PubMed ID: 17661640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]